摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-benzoyl-1,2,3,4-tetrahydrobenzo-1,5-naphthyridine | 106351-32-0

中文名称
——
中文别名
——
英文名称
1-benzoyl-1,2,3,4-tetrahydrobenzo-1,5-naphthyridine
英文别名
1-benzoyl-1,2,3,4-tetrahydrobenzo[c]-1,5-naphthyridine;3,4-dihydro-2H-benzo[h][1,5]naphthyridin-1-yl(phenyl)methanone
1-benzoyl-1,2,3,4-tetrahydrobenzo<c>-1,5-naphthyridine化学式
CAS
106351-32-0
化学式
C19H16N2O
mdl
——
分子量
288.349
InChiKey
IJPVMQXHQCSBGJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    22
  • 可旋转键数:
    1
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.16
  • 拓扑面积:
    33.2
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Synthesis of novel 1,2,3,4-tetrahydrobenzo[<i>c</i>]-1,5-naphthyridines from pyrrolo[1,2-<i>b</i>]isoquinolines
    作者:Lawrence L. Martin、Susan J. Scott、Linda L. Setescak、Donna Van Engen
    DOI:10.1002/jhet.5570240609
    日期:1987.11
    (5a) was prepared by a novel synthetic route involving the rearrangement of (±)-(Z)-1,10a-dihydropyrrolo[1,2-b]isoquinoline-3,10(2H,5H)-dione oxime to afford 1,4-dihydrobenzo[c]-1,5-naphthyridin-2(3H)-one, which was reduced to 5a. The cholinomimetic activity observed with 5a prompted the synthesis and biological evaluation of additional analogues.
    1,2,3,4-四氢苯并[ c ] -1,5-萘啶(5a)是通过涉及(±)-(Z)-1,10a-二氢吡咯并[1,2- b ]异喹啉-3,10(2 H,5 H)-二酮肟制得1,4-二氢苯并[ c ] -1,5-萘啶-2(3 H)-一,还原为5a。用5a观察到的拟胆碱活性促使其他类似物的合成和生物学评估。
  • Benzo(c)-1,5-naphthyridines useful for treating a patient having drug
    申请人:Hoechst-Roussel Pharmaceuticals Inc.
    公开号:US04652567A1
    公开(公告)日:1987-03-24
    There are disclosed novel compounds of the formula ##STR1## where X is H, halogen, loweralkyl, loweralkoxy, --CF.sub.3, or --OH; R is H, loweralkyl, arylloweralkyl, diarylloweralkyl, loweralkanoyl, arylloweralkanoyl or diarylloweralkanoyl; and R.sub.1 is H.sub.2, O or --NR.sub.2 R.sub.3, R.sub.2 and R.sub.3 being independently H or loweralkyl, or taken together with the nitrogen atom to which they are attached constitute ##STR2## R.sub.4 in turn being H, loweralkyl, hydroxyloweralkyl, aryl, arylloweralkyl or diarylloweralkyl or pharmaceutically acceptable acid addition salts thereof, which are useful for enhancing memory.
    公开了一种新型化合物,其化学式为##STR1##其中X为H、卤素、低碳基、低氧基、--CF.sub.3或--OH;R为H、低碳基、芳基低碳基、二芳基低碳基、低碳酰基、芳基低碳酰基或二芳基低碳酰基;R.sub.1为H.sub.2、O或--NR.sub.2 R.sub.3,其中R.sub.2和R.sub.3独立地为H或低碳基,或与它们连接的氮原子一起构成##STR2##R.sub.4又为H、低碳基、羟基低碳基、芳基、芳基低碳基或二芳基低碳基,或其药学上可接受的酸盐,其用于增强记忆。
  • Dihydropyrrolo[1,2-b]isoquinolinedione oximes
    申请人:Hoechst-Roussel Pharmaceuticals Inc.
    公开号:US04670562A1
    公开(公告)日:1987-06-02
    There is disclosed novel compounds of the formula ##STR1## where X is H, halogen, loweralkyl, loweralkoxy, -CF.sub.3, or -OH; R is H, loweralkyl, arylloweralkyl, diarylloweralkyl, loweralkanoyl, arylloweralkanoyl or diarylloweralkanoyl; and R.sub.1 is H.sub.2, O or --NR.sub.2 R.sub.3, R.sub.2 and R.sub.3 being independently H or loweralkyl, or taken together with the nitrogen atom to which they are attached constitute ##STR2## R.sub.4 in turn being H, loweralkyl, hydroxyloweralkyl, aryl, arylloweralkyl or diarylloweralkyl or pharmaceutically acceptable acid addition salts thereof, which are useful for enchancing memory.
    公开了新型化合物的公式 ##STR1## 其中X为H、卤素、低烷基、低烷氧基、-CF.sub.3或-OH; R为H、低烷基、芳基低烷基、二芳基低烷基、低烷酰基、芳基低烷酰基或二芳基低烷酰基; R.sub.1为H.sub.2、O或--NR.sub.2 R.sub.3,其中R.sub.2和R.sub.3独立地为H或低烷基,或与它们连接的氮原子一起构成 ##STR2## R.sub.4则为H、低烷基、羟基低烷基、芳基、芳基低烷基或二芳基低烷基或其药学上可接受的酸盐,用于增强记忆。
  • Method of synthesizing 1,4-dihydro-benzo[c]-1,5-naphthyridin-2(3H)-ones
    申请人:Hoechst-Roussel Pharmaceuticals Inc.
    公开号:US04742171A1
    公开(公告)日:1988-05-03
    There is described a method of synthesizing 1,4-dihydro-benzo[c]-1,5-naphthyridin-2(3H)-ones having the formula ##STR1## where X is hydrogen, halogen, loweralkyl, loweralkoxy, trifluoromethyl or hydroxy, which method consists essentially of the aromatization and rearrangement of 1,10a-dihydropyrrolo[1,2-b]isoquinoline-3,10(2H,5H)-dione oximes of the formula below: ##STR2##
    描述了一种合成具有以下公式的1,4-二氢苯并[c]-1,5-萘啉-2(3H)-酮的方法:##STR1## 其中X是氢,卤素,较低烷基,较低烷氧基,三氟甲基或羟基,该方法基本上包括以下化合物的芳香化和重排:1,10a-二氢吡咯并[1,2-b]异喹啉-3,10(2H,5H)-二酮肟的公式如下:##STR2##
  • Benzoc[c]-1,5-naphthyridines and related compounds as memory enhancing
    申请人:Hoechst-Roussel Pharmaceuticals Inc.
    公开号:US04742061A1
    公开(公告)日:1988-05-03
    There are disclosed novel compounds of the formula ##STR1## where m is 1 or 2; each X is independently H, halogen, loweralkyl, loweralkoxy, --CF.sub.3, or --OH; R is H, loweralkyl, chloroloweralkyl, bromoloweralkyl, iodoloweralkyl, aminoloweralkyl, loweralkylaminoloweralkyl, diloweralkylaminoloweralkyl, arylloweralkyl, diarylloweralkyl, thienylloweralkyl, furylloweralkyl, loweralkanoyl, chloroloweralkanoyl, bromoloweralkanoyl, iodoloweralkanoyl, aminoloweralkanoyl, loweralkylaminoloweralkanoyl, diloweralkylaminoloweralkanoyl, aroyl, arylloweralkanoyl or diarylloweralkanoyl, thienylloweralkanoyl, furylloweralkanoyl; and R.sub.1 is .dbd.O, ##STR2## or --NR.sub.2 R.sub.3, R.sub.2 and R.sub.3 being independently H or loweralkyl, or taken together with the nitrogen atom to which they are attached constituting ##STR3## R.sub.4 in turn being H, loweralkyl, hydroxyloweralkyl, aryl, arylloweralkyl or diarylloweralkyl, with the proviso that when R.sub.1 is --NR.sub.2 R.sub.3, R is nonexistent, that when R.sub.1 is .dbd.O, R is not an acyl group and that when R.sub.1 is ##STR4## R is not chloroloweralkyl, bromoloweralkyl or iodoloweralkyl; or pharmaceutically acceptable acid addition salts thereof, which are useful for enhancing memory.
    公开了新的化合物,其化学式为## STR1 ##,其中m为1或2;每个X独立地为H,卤素,较低的烷基,较低的烷氧基,-CF.sub.3或-OH;R为H,较低的烷基,氯代较低的烷基,溴代较低的烷基,碘代较低的烷基,氨基较低的烷基,较低的烷基氨基较低的烷基,双较低的烷基氨基较低的烷基,芳基较低的烷基,二芳基较低的烷基,噻吩基较低的烷基,呋喃基较低的烷基,较低的烷酰基,氯代较低的烷酰基,溴代较低的烷酰基,碘代较低的烷酰基,氨基较低的烷酰基,较低的烷基氨基较低的烷酰基,二较低的烷基氨基较低的烷酰基,芳基,芳基较低的烷酰基或二芳基较低的烷酰基,噻吩基较低的烷酰基,呋喃基较低的烷酰基;R.sub.1为.dbd.O,## STR2 ##或-NR.sub.2R.sub.3,其中R.sub.2和R.sub.3独立地为H或较低的烷基,或与它们连接的氮原子一起构成## STR3 ##,R.sub.4反过来为H,较低的烷基,羟基较低的烷基,芳基,芳基较低的烷基或二芳基较低的烷基,但有一个前提,即当R.sub.1为-NR.sub.2R.sub.3时,R不存在,当R.sub.1为.dbd.O时,R不是酰基,当R.sub.1为## STR4 ##时,R不是氯代较低的烷基,溴代较低的烷基或碘代较低的烷基;或其药学上可接受的酸盐,可用于增强记忆。
查看更多